Asthma is one of the most prevalent chronic inflammatory respiratory diseases across the globe, with a significant increase in mortality and morbidity in recent years, affecting all age groups ...
Please provide your email address to receive an email when new articles are posted on . Global Initiative for Asthma (GINA) guidelines recommend single maintenance and reliever therapy (SMART) for ...
GRAND RAPIDS, Mich. (WOOD) — Many people manage their asthma with an inhaler — but they may not be using it correctly. Studies show that nearly 90% of patients with an inhaler make at least one ...
Medics have warned that some asthma sufferers using blue inhalers could be putting their health at risk. More than seven million Brits are living with asthma, according to Asthma and Lung UK. An ...
Researchers have found that more than a quarter of asthma patients are still over-using inhalers intended for rapid relief of symptoms. Overuse of these inhalers is linked to an increased risk of ...
Dr. Miguel Divo, a lung specialist at Brigham and Women’s Hospital, sits in an exam room, across from one of his patients with asthma. Joel Rubinstein, a retired psychiatrist, is about to get a ...
Active ingredient: Ciclesonide 80 µg/inhalation, 160 µg/inhalation; metered-dose inhaler. Indication: Maintenance treatment of asthma as prophylactic therapy in patients >12 years of age. Pharmacology ...
Researchers in the United Kingdom compared the potential impact on carbon footprint and asthma symptom control of switching maintenance therapy to a dry powder inhaler vs continuing with a metered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results